期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 562, 期 -, 页码 249-257出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2019.03.013
关键词
Cationic; Polymer; Nanoparticles; Drug delivery; Intracellular; siRNA
资金
- National Institutes of Health [R01-EB022025-2, R01-EB00246-18]
- National Science Foundation [1033746]
- William Tex Moncrief, Jr. Foundation
- Pratt Foundation
- Cockrell Family Regents Chair
- U.S. National Science Foundation
- Directorate For Engineering
- Div Of Chem, Bioeng, Env, & Transp Sys [1033746] Funding Source: National Science Foundation
The progress of short interfering RNA (siRNA) technologies has unlocked the development of novel alternatives for the treatment of a myriad of diseases, including viral infections, autoimmune disorders, or cancer. Nevertheless, the clinical use of these therapies faces significant challenges, mainly overcoming the charged and large nature of these molecules to effectively enter the cell. In this work, we developed a cationic polymer nanoparticle system that is able to load siRNA due to electrostatic interactions. The pH-responsiveness and membrane-disrupting ability of these carriers make them suitable intracellular delivery vehicles. In the work presented herein we synthesized, characterized, and evaluated the properties of nanoparticles based on 2-diethylaminoethyl methacrylate and tertbutyl methacrylate copolymers. A disulfide crosslinker was incorporated in the nanogels to enable the degradation of the nanoparticles in reductive environments, showing no significant changes on their physicochemical properties. The capability of the developed nanogels to be internalized, deliver siRNA, and induce gene knockdown were demonstrated using a human epithelial colorectal adenocarcinoma cell line. Overall, these findings suggest that this platform exhibits desirable characteristics as a potential siRNA-delivery platform.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据